Literature DB >> 16488526

[Squamous cell carcinoma arising in Verneuil's disease: two cases and literature review].

J-C Talmant1, C Bruant-Rodier, A C Nunziata, J F Rodier, A Wilk.   

Abstract

Verneuil's disease (hidradenitis suppurativa) is a chronic inflammatory, suppurating, fistulizing and scar-producing disease of apocrine gland-bearing skin. Its transformation into epidermoid carcimona has been reported 38 times in literature. We describe two new cases - two males aged 67 and 68-years-old. The first one is still alive with no recurrence after one year and the second patient died 2 months after surgery, showing generalised scattering. This rare complication is interesting for two reasons. It only concerns perianal location and it targets mainly men. Surgical treatment consists of wide excision. However, it is often too late. The outcomes are critical for it has been reported a 50% rate of deaths within 2 years after surgery. It is therefore imperative that both general practitioners and dermatologists follow patients with Verneuil's disease so that they can propose a preventive excision at the right time.

Entities:  

Mesh:

Year:  2006        PMID: 16488526     DOI: 10.1016/j.anplas.2005.11.002

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  3 in total

1.  Comorbidities of hidradenitis suppurativa (acne inversa).

Authors:  Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2010-01

2.  Squamous Cell Carcinoma in Perineal, Perianal, and Gluteal Hidradenitis Suppurativa: Experience in 12 Patients.

Authors:  John J Kohorst; Kabeer K Shah; Christopher L Hallemeier; Christian L Baum; Mark D P Davis
Journal:  Dermatol Surg       Date:  2019-04       Impact factor: 3.398

3.  Acne inversa of the scrotum and penis - aggressive urological treatment.

Authors:  Artur Gibas; Marcin Matuszewski; Igor Michajłowski; Kazimierz Krajka
Journal:  Cent European J Urol       Date:  2012-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.